Evidence map›Paper›PMID 28165055›Full record

ArticleScientific reports2017

Human embryonic and induced pluripotent stem cells maintain phenotype but alter their metabolism after exposure to ROCK inhibitor.

Spyros I Vernardis, Konstantinos Terzoudis, Nicki Panoskaltsis, Athanasios Mantalaris

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Spyros I VernardisBiological Systems Engineering Laboratory, Department of Chemical Engineering, Imperial College London, UK.
Konstantinos TerzoudisBiological Systems Engineering Laboratory, Department of Chemical Engineering, Imperial College London, UK.
Nicki PanoskaltsisBiological Systems Engineering Laboratory, Department of Chemical Engineering, Imperial College London, UK.
Athanasios MantalarisBiological Systems Engineering Laboratory, Department of Chemical Engineering, Imperial College London, UK.
Imperial College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human pluripotent stem cells (hPSCs) are adhesion-dependent cells that require cultivation in colonies to maintain growth and pluripotency. Robust differentiation protocols necessitate single cell cultures that are achieved by use of ROCK (Rho kinase) inhibitors. ROCK inhibition enables maintenance of stem cell phenotype; its effects on metabolism are unknown. hPSCs were exposed to 10 μM ROCK inhibitor for varying exposure times. Pluripotency (TRA-1-81, SSEA3, OCT4, NANOG, SOX2) remained unaffected, until after prolonged exposure (96 hrs). Gas chromatography-mass spectrometry metabolomics analysis identified differences between ROCK-treated and untreated cells as early as 12 hrs. Exposure for 48 hours resulted in reduction in glycolysis, glutaminolysis, the citric acid (TCA) cycle as well as the amino acids pools, suggesting the adaptation of the cells to the new culture conditions, which was also reflected by the expression of the metabolic regulators, mTORC1 and tp53 and correlated with cellular proliferation status. While gene expression and protein levels did not reveal any changes in the physiology of the cells, metabolomics revealed the fluctuating state of the metabolism. The above highlight the usefulness of metabolomics in providing accurate and sensitive information on cellular physiological status, which could lead to the development of robust and optimal stem cell bioprocesses.

Indexed as

MetabolomeAmidesAntigens, SurfaceAntigens, Tumor-Associated, CarbohydrateBiomarkersCell DifferentiationCell ProliferationCells, CulturedEmbryonic Stem CellsEnzyme InhibitorsGene ExpressionHumansInduced Pluripotent Stem CellsMechanistic Target of Rapamycin Complex 1Nanog Homeobox ProteinOctamer Transcription Factor-3AmidesAntigens, SurfaceAntigens, Tumor-Associated, CarbohydrateBiomarkersEnzyme InhibitorsMechanistic Target of Rapamycin Complex 1Nanog Homeobox ProteinNANOG protein, humanOctamer Transcription Factor-3POU5F1 protein, humanPyridinesReactive Nitrogen SpeciesReactive Oxygen Speciesrho-Associated KinasesSOX2 protein, humanSOXB1 Transcription Factorsstage-specific embryonic antigen-3Stage-Specific Embryonic AntigensTP53 protein, humanTRA-1-81 antigen, humanTumor Suppressor Protein p53Y 27632

Identifiers

PMID28165055
PMCPMC5292706
OpenAlexW2587043905

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.